Clinical Laserthermia Systems
4.35 SEK
+1.05 %
CLS B
First North Stockholm
Medical Equipment & Services
Health Care
Clinical Laserthermia Systems operates in the medical technology sector. The company's vision is to develop and streamline the treatment of solid cancer tumors, where the company is a seller of sterile patient kits. The products are used in various cancer treatments such as in the treatment of malignant melanoma, as well as cancer of the lungs, liver and pancreas. The company was founded in 2006 and has its headquarters in Lund.
Read moreRevenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
General meeting '26
Interim report Q2'26
Interim report Q3'26
CLS publicerar delårsrapport januari - mars 2026
CLS Publishes Interim Report January - March 2026
Join Inderes community
Don't miss out - create an account and get all the possible benefits